Home › Funds › Two Sigma Investments › TSHA
Two Sigma Investments position in TSHA
TAYSHA GENE THERAPIES INC · Health Care
Latest position (Q2 2026)234.72K sh
Reported value held$1.60M
Portfolio Weight0.00%
First reportedQ4 2021
Last changeReduce
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2021 | 69.23K | $807.00K | New |
| Q1 2022 | 181.91K | $1.19M | Add |
| Q2 2022 | 67.64K | $252.00K | Reduce |
| Q3 2022 | 43.38K | $84.00K | Reduce |
| Q4 2023 | 136.97K | $242.44K | New |
| Q1 2024 | 121.52K | $348.75K | Reduce |
| Q4 2024 | 12.30K | $21.28K | New |
| Q2 2025 | 32.68K | $75.50K | New |
| Q3 2025 | 66.11K | $216.16K | Add |
| Q4 2025 | 351.13K | $1.93M | Add |
| Q1 2026 | 742.08K | $3.32M | Add |
| Q2 2026 | 234.72K | $1.60M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding TSHA
- Goldman Sachs Group 22.71M sh · $154.68M · Q2 2026
- BlackRock Inc 20.69M sh · $140.91M · Q2 2026
- Morgan Stanley 16.49M sh · $112.28M · Q2 2026
- Fidelity Management & Research (FMR) 13.34M sh · $90.82M · Q2 2026
- Vanguard Group 13.27M sh · $72.97M · Q4 2025
- Geode Capital Management 6.56M sh · $44.69M · Q2 2026
- D. E. Shaw & Co 4.40M sh · $29.95M · Q2 2026
- Wellington Management Group 3.98M sh · $27.07M · Q2 2026
- Casdin Capital 3.25M sh · $22.13M · Q2 2026
- Farallon Capital Management 2.25M sh · $15.32M · Q2 2026
- Norges Bank Investment Management 2.23M sh · $15.21M · Q2 2026
- Northern Trust Corp 2.23M sh · $15.16M · Q2 2026